Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension

ATS Statement

2002 • 9,250 citations

Survival in Patients with Primary Pulmonary Hypertension

1991 • 3,369 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

Clinical classification of pulmonary hypertension

2004 • 1,915 citations

Treatment of Pulmonary Arterial Hypertension

2004 • 1,673 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

2002 • 1,383 citations

Survival in Primary Pulmonary Hypertension

2002 • 1,192 citations

Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

2005 • 1,135 citations

Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension

2000 • 1,129 citations

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

2004 • 1,041 citations

Survival with first-line bosentan in patients with primary pulmonary hypertension

2005 • 611 citations

Haemodynamic evaluation of pulmonary hypertension

2002 • 333 citations

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

1995 • 303 citations

Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension

2003 • 292 citations

Increased Endothelin-1 in Bleomycin-induced Pulmonary Fibrosis and the Effect of an Endothelin Receptor Antagonist

1997 • 241 citations

Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension

2003 • 145 citations

Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats

1995 • 128 citations

Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats

1997 • 98 citations

Bosentan therapy for pulmonary arterial hypertension

2004 • 34 citations